Signature Resources Appoints John Hayes as an Advisor to Management and the Board of Directors
January 27, 2021 08:30 ET
|
Signature Resources Ltd.
TORONTO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Signature Resources Ltd. (TSXV: SGU, OTCQB: SGGTF, FSE 3S3) ("Signature" or the "Company") is pleased to announce the appointment of John Hayes as an...
Nasdaq Grants Guardion Health Sciences an Extension to March 15, 2021 to Regain Compliance with the $1.00 Minimum Bid Price Rule
January 27, 2021 08:30 ET
|
Guardion Health Sciences, Inc.
SAN DIEGO, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Guardion Health Sciences, Inc. (Nasdaq: GHSI) (“Guardion” or the “Company”), a specialty health sciences company that develops clinically supported...
Global Boatworks Holdings Executes LOI for Strategic Partnership with Technology Transfer Institute to Expand User Experience and Machine Learning Capabilities
January 27, 2021 08:30 ET
|
Global Boatworks Holdings Inc.
BALTIMORE, MD, Jan. 27, 2021 (GLOBE NEWSWIRE) -- via NewMediaWire -- Global Boatworks Holdings, Inc. (OTC: GBBT), ("Global" or "the Company") announced it has executed a letter of intent (LOI) with...
Cellectar Receives Orphan Drug Designation from the European Commission for CLR 131 in Waldenstrom’s Macroglobulinemia
January 27, 2021 08:30 ET
|
Cellectar Biosciences
FLORHAM PARK, N.J., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a late-stage clinical biopharmaceutical company focused on the discovery, development, and...
Jones Soda Launches Variety 12-Packs & Special Release Flavors
January 27, 2021 08:30 ET
|
Jones Soda Co.
SEATTLE, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Jones Soda Co. (OTCQB: JSDA), the original craft soda known for its unconventional flavors and user-designed label artwork, is ramping up its growth...
3D Systems Announces Breakthrough in Bioprinting Technology and Expansion of Regenerative Medicine Initiative
January 27, 2021 08:30 ET
|
3D Systems Inc.
Demonstration of high rate, micron-level printing capability enabling vascularization required to sustain living cellsCritical technology elements reach level required to dramatically expand...
Veru to Report Fiscal 2021 First-Quarter Financial Results, Host Conference Call on February 10th
January 27, 2021 08:30 ET
|
Veru Inc.
MIAMI, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), an oncology biopharmaceutical company with a focus on developing novel medicines for the management of prostate and breast cancer,...
Vaxart Announces Publication of a Peer-reviewed Journal Article Showing the Potential Clinical and Economic Value of a Norovirus Vaccine
January 27, 2021 08:30 ET
|
Vaxart, Inc.
A computational simulation model showed that a norovirus vaccine costing as much as $1,300 can still be cost saving in children under 5 The model also showed a norovirus vaccine costing $100 can be...
Ultimus Names Joe Bree to Key Business Development Position
January 27, 2021 08:30 ET
|
Ultimus Fund Solutions
CINCINNATI, Ohio, Jan. 27, 2021 (GLOBE NEWSWIRE) -- As a leading independent provider of full-service fund administration, accounting, and investor solutions, Ultimus Fund Solutions® (Ultimus®) is...
C-Bond Ballistic-Resistant System in Initial Trial with Leading Provider of Custom Structures for a Top Mass Retailer
January 27, 2021 08:30 ET
|
C-Bond Systems
HOUSTON, Jan. 27, 2021 (GLOBE NEWSWIRE) -- C-Bond Systems (the “Company” or “C-Bond”) (OTC: CBNT), a nanotechnology solutions company, today announced that its C-Bond BRS (ballistic-resistant...
- May 25, 2024 09:40 ET Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
- May 24, 2024 20:18 ET Stockholder Alert: Robbins LLP Informs Investors that a Shareholder Has Filed a Class Action Against Biogen Inc. (BIIB)